Literature DB >> 33038188

Predictors of Out-of-Class Mindfulness Practice Adherence During and After a Mindfulness-Based Intervention.

Nicholas K Canby1, Kristina Eichel, Sarah I Peters, Hadley Rahrig, Willoughby B Britton.   

Abstract

OBJECTIVE: Out-of-class mindfulness meditation practice is a health behavior that is considered to be a crucial ingredient in mindfulness-based interventions (MBIs), yet participant adherence to practice recommendations is often inconsistent. Furthermore, MBIs may enhance factors that lead to greater adherence to medical regimens in other contexts. This study examined baseline factors previously found to relate to adherence to medical regimen, MBI-related changes in these baseline factors, and treatment-related factors as predictors of meditation adherence in an 8-week MBI.
METHODS: Baseline traits (personality, depressive symptoms, and executive function) were entered into regression models (n = 96) to predict intervention and postintervention out-of-class meditation adherence. Trait changes and treatment-related factors were entered into models to predict postintervention meditation adherence.
RESULTS: Baseline conscientiousness (β = 0.33, p = .002), openness (β = 0.23, p = .019), and depressive symptoms (β = 0.19, p = .042) predicted intervention meditation adherence, whereas conscientiousness (β = 0.21, p = .044) and depressive symptoms (β = 0.22, p = .020) predicted postintervention meditation adherence. Although all trait variables except for agreeableness changed significantly pre-to-post intervention, these changes did not predict postintervention meditation adherence. Retreat attendance (β = 0.38, p = .029) and instructor/group-related therapeutic factors collectively predicted postintervention meditation adherence (R2 = 0.21, p = .019).
CONCLUSIONS: The identified baseline trait factors could be used to increase adherence in these interventions as a method of increasing their effectiveness. An emphasis on the MBI retreat and social factors during the intervention may be important for participant out-of-class practice postintervention.Trial Registration:ClinicalTrials.govNCT01831362.
Copyright © 2020 by the American Psychosomatic Society.

Entities:  

Mesh:

Year:  2021        PMID: 33038188      PMCID: PMC8024418          DOI: 10.1097/PSY.0000000000000873

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  40 in total

1.  Conscientiousness and mindfulness in midlife coping: An assessment based on MIDUS II.

Authors:  Amanda A Sesker; Páraic Ó Súilleabháin; Siobhán Howard; Brian M Hughes
Journal:  Personal Ment Health       Date:  2015-11-22

2.  Daily Mindful Responding Mediates the Effect of Meditation Practice on Stress and Mood: The Role of Practice Duration and Adherence.

Authors:  Julien Lacaille; Gentiana Sadikaj; Midori Nishioka; Kimberly Carrière; Joseph Flanders; Bärbel Knäuper
Journal:  J Clin Psychol       Date:  2017-07-31

3.  Self-reported mindfulness and cortisol during a Shamatha meditation retreat.

Authors:  Tonya L Jacobs; Phillip R Shaver; Elissa S Epel; Anthony P Zanesco; Stephen R Aichele; David A Bridwell; Erika L Rosenberg; Brandon G King; Katherine A Maclean; Baljinder K Sahdra; Margaret E Kemeny; Emilio Ferrer; B Alan Wallace; Clifford D Saron
Journal:  Health Psychol       Date:  2013-03-25       Impact factor: 4.267

Review 4.  Mindfulness Meditation and Psychopathology.

Authors:  Joseph Wielgosz; Simon B Goldberg; Tammi R A Kral; John D Dunne; Richard J Davidson
Journal:  Annu Rev Clin Psychol       Date:  2018-12-10       Impact factor: 18.561

Review 5.  Patient adherence to treatment: three decades of research. A comprehensive review.

Authors:  E Vermeire; H Hearnshaw; P Van Royen; J Denekens
Journal:  J Clin Pharm Ther       Date:  2001-10       Impact factor: 2.512

6.  Factors Associated with Attrition from Mindfulness-Based Cognitive Therapy in Patients with a History of Suicidal Depression.

Authors:  Catherine Crane; J Mark G Williams
Journal:  Mindfulness (N Y)       Date:  2010-03-11

7.  The Inventory for Depressive Symptomatology (IDS): preliminary findings.

Authors:  A J Rush; D E Giles; M A Schlesser; C L Fulton; J Weissenburger; C Burns
Journal:  Psychiatry Res       Date:  1986-05       Impact factor: 3.222

8.  Cognitive function and treatment adherence in older adults with heart failure.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Manfred van Dulmen; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  Psychosom Med       Date:  2012-10-31       Impact factor: 4.312

9.  The influence of personality traits on reported adherence to medication in individuals with chronic disease: an epidemiological study in West Sweden.

Authors:  Malin Axelsson; Eva Brink; Jesper Lundgren; Jan Lötvall
Journal:  PLoS One       Date:  2011-03-28       Impact factor: 3.240

Review 10.  Home practice in Mindfulness-Based Cognitive Therapy and Mindfulness-Based Stress Reduction: A systematic review and meta-analysis of participants' mindfulness practice and its association with outcomes.

Authors:  Christine E Parsons; Catherine Crane; Liam J Parsons; Lone Overby Fjorback; Willem Kuyken
Journal:  Behav Res Ther       Date:  2017-05-10
View more
  3 in total

1.  Harnessing Life's Slings and Arrows: The Science and Opportunities for Mindfulness Meditation During a Global Pandemic and Beyond.

Authors:  Eric B Loucks; Melissa A Rosenkranz; J David Creswell
Journal:  Psychosom Med       Date:  2021 Jul-Aug 01       Impact factor: 4.312

2.  The Effectiveness of Mindfulness-Based Cognitive Therapy in Primary Care and the Role of Depression Severity and Treatment Attendance.

Authors:  Matilde Elices; Víctor Pérez-Sola; Adrián Pérez-Aranda; Francesc Colom; Maria Polo; Luis Miguel Martín-López; Miguel Gárriz
Journal:  Mindfulness (N Y)       Date:  2021-11-29

3.  Mindfulness and More: Toward a Science of Human Flourishing.

Authors:  Richard J Davidson
Journal:  Psychosom Med       Date:  2021 Jul-Aug 01       Impact factor: 4.312

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.